HIV Update: The 'HIV Conserv’ Vaccine And Its Promising Results
A researcher has recently revealed that HIV patients may have just found themselves a new hope after several HIV patients have been treated in a small-scale clinical trial with the help of a therapeutic vaccine strategy that appears to have the ability of controlling the virus without drugs. It is said that a so-called 'HIV Conserv' vaccine has, for the first time, produced significant prolonged viral control in a large minority of recipients once they were taken off antiretroviral therapy (ART). The findings have been presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017).
The 'HIV Conserv'
In one of her statements reported by Medpage Today, Beatriz Mothe, MD, PhD, of the Spanish AIDS research institute IrsiCaixa in Barcelona said that they go up and down but their HIV viral load remains relatively low. On the other hand, she explains that eight other patients in the trial immediately saw their HIV rebound after they stopped therapy and had to resume taking their drugs. Consequently, Mothe claims that by far, the results are the "first potential signal" that a therapeutic vaccine, in this case combined with a drug that activates HIV-infected cells and makes them a target of the immune system, can have a beneficial effect.
Furthermore, according to reports revealed by AidsMap, HIV Conserv vaccines contain selected antigens (immune-stimulating sequences of proteins or genes) from HIV that are highly conserved, which is where the name has originated from. Experts said that being highly conserved means that they are the parts of HIV the virus can least afford to change, and which vary little from one virus to another. Thus, the vaccines are said to consist of sections of proteins from different strains of HIV that have been stitched together, which, in turn, generates an immune response to HIV that the virus finds it hard to escape from.
Meanwhile, it was found that after three years of standard HIV therapy, the patients were given booster shots of another vaccine, MVA.HIV conserv, combined with romidepsin or commonly called Istodax, which is a drug that activates latent T cells that can harbor HIV. As of the press time, Mothe reveals that she and her team will allegedly continue to monitor the patients and to try to find ways to improve the outcome in future studies. Ultimately, another expert, Peter Hunt, MD, of the University of California San Francisco, who was not part of the study commented that the study is a measurable step forward.
The Power Of Cannabis Sheds Light In The Fight Against Brain Cancer
Considering that a lot of US’ states have been considering the legalization of cannabis and others have already been legalizing it, what’s the truth behind new claims that it can potentially be used as the secret weapon against brain cancer? Could it be the cure that can pave the way for other treatments involving cannabis? Find out what experts have to say about it
Ebola Update: This New Breakthrough ‘Scorecard’ Will To Make It Easier To Fight Ebola
As the Ebola scare is still being felt, how does researchers plan to eradicate this pandemic problem? What's the truth behind clams that an alleged 'scorecard' can potentially help scientists in their quest to end the disease? How essential could it get? Find out what experts have to say
Vitamin D Finally Sheds Light To Answering A Number Of Winter Infections
Considering the prevalence of a number of winter infections such as colds and flu, what’s the truth behind claims that Vitamin D intake could have the ability of stopping these illnesses from ever taking place? Have we just found ourselves the right protection from these diseases? Find out what experts have to say
HIV, The Next Target Of Trump Administration
As continuous efforts to eradicate HIV are taking place, why does the Trump administration wanted to halt the treatment that has been started by the previous government? What’s the truth behind claims that if the current US President would push this through, it will kill thousands? Find out what authorities have to say
How Do We Reduce HIV Risk? Here Are Experts' Tips
With the continuous efforts to eradicate one of the world's long dreaded disease, can we really do certain precautionary measures to prevent the risk of HIV? What are the necessary steps to prevent transmission of the disease? Find out what experts have to say
HIV Vaccine Cures Five Patients For Seven Months
New AIDS vaccine developed in Spain have reportedly cured 5 patients, helping them remain virus-free for seven months after taking the treatment. In the study, the treatment allowed the patients to stop taking regular antiretroviral (ARV) drugs to suppress HIV symptoms.
MORE IN ITECHPOST
The Role of Technology in Education in 2019
2019 is proving to be another great year for trends in educational technology. There are many upcoming trends that seem to have a bearing on the future of the sector with respect to technology.
New Retroreflective Material Could be Used in Nighttime Color-Changing Road Signs
BUFFALO, N.Y. -- A thin film that reflects light in intriguing ways could be used to make road signs that shine brightly and change color at night, according to a study that will be published on Aug. 9 in Science Advances.
Top 5 Video Games to Play for a Truly Unique First Date
Video games have a way of taking us outside of ourselves and live in a fantasy world. It's even better when you're playing a game with someone special!